Identity
HGNC
LOCATION
Xp11.23
LOCUSID
ALIAS
H3-K9-HMTase 1,KMT1A,MG44,SUV39H
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 6839
MIM: 300254
HGNC: 11479
Ensembl: ENSG00000101945
Variants:
dbSNP: 6839
ClinVar: 6839
TCGA: ENSG00000101945
COSMIC: SUV39H1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000101945 | ENST00000337852 | O43463 |
| ENSG00000101945 | ENST00000376687 | O43463 |
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38176898 | 2024 | Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis. | 1 |
| 38177411 | 2024 | The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma. | 0 |
| 38176898 | 2024 | Histone methyltransferase Suv39h1 regulates hepatic stellate cell activation and is targetable in liver fibrosis. | 1 |
| 38177411 | 2024 | The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma. | 0 |
| 37029239 | 2023 | SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma. | 0 |
| 38017386 | 2023 | SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. | 2 |
| 37029239 | 2023 | SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma. | 0 |
| 38017386 | 2023 | SUV39H1 is a novel biomarker targeting oxidative phosphorylation in hepatitis B virus-associated hepatocellular carcinoma. | 2 |
| 35768432 | 2022 | CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas. | 13 |
| 36149194 | 2022 | Differences in SUV39H1 and androgen receptor distribution in adenomyomatous hyperplasia and prostatic adenocarcinoma. | 0 |
| 36536372 | 2022 | Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4(+) T cells from patients with systemic lupus erythematosus. | 0 |
| 35768432 | 2022 | CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas. | 13 |
| 36149194 | 2022 | Differences in SUV39H1 and androgen receptor distribution in adenomyomatous hyperplasia and prostatic adenocarcinoma. | 0 |
| 36536372 | 2022 | Decreased SUV39H1 at the promoter region leads to increased CREMα and accelerates autoimmune response in CD4(+) T cells from patients with systemic lupus erythematosus. | 0 |
| 33196969 | 2021 | MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression. | 10 |
Citation
Dessen P
SUV39H1 (suppressor of variegation 3-9 homolog 1)
Atlas Genet Cytogenet Oncol Haematol. 2007-02-01
Online version: http://atlasgeneticsoncology.org/gene/43860/suv39h1
